Persistent URL of this record https://hdl.handle.net/1887/95210
In Collections
This item can be found in the following collections:
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase 1/11 results of the EORTC/GIMEMA AML-14A trial
- All authors
- Selleslag, D.; Suciu, S.; Meloni, G.; Muus, P.; Halkes, C.J.M.; Venditti, A.; Ramadan, S.M.; Pruijt, H.; Meert, L.; Vignetti, M.; Marie, J.P.; Wittnebel, S.; Witte, T. de; Amadori, S.; Willemze, R.; Baron, F.
- Date
- 2017-02-28
- Journal
- Haematologica
- Volume
- 102
- Issue
- 2
- Pages
- E47 - E51